Biobot Surgical Pte Ltd was incorporated in 2007 in Singapore, and became a member of ZIG Ventures since 2013. To ensure success, a team of talents has been put together in the areas of robotic design and technology, medical image processing, software development and clinical application. To date, the iSR’obot Mona Lisa has obtained key regulatory approvals, including Europe (CE mark), U.S.A (US FDA), Australia (TGA) and Singapore (HSA) and is being used in some of the most prestigious hospitals around the world. Striving to become the gold standard in diagnosis and prognosis of prostate cancer, the Mona Lisa’s development has been a process of evolution and is the latest in our state of the art new generation designs.

Biobot Surgical

Intuitive is a company specializing in robotic-assisted surgical systems, including those for prostate procedures.

Intuitive

Corindus Vascular Robotics focuses on developing robotic-assisted systems for vascular interventions, with potential applications in prostate procedures.

Corindus Vascular Robotics

CMR Surgical is a company specializing in surgical robotics, with a focus on minimal access surgery, which could be relevant to prostate procedures.

CMR Surgical

PROCEPT BioRobotics is known for developing an advanced surgical robotic system specifically for the treatment of prostate conditions.

PROCEPT BioRobotics

Accuray specializes in radiation oncology, with a focus on precise, innovative treatment solutions, including those for prostate cancer.

Accuray

Triopsy is involved in the diagnosis and treatment of various conditions, including prostate cancer, potentially offering competitive solutions.

Triopsy

BXT-Accelyon specializes in the diagnosis and treatment of prostate cancer, offering innovative solutions in this field.

BXT-Accelyon

Biobot is a company that specializes in robotic transperineal prostate procedures, aiming to bridge the gap in prostate cancer care by providing transformative solutions.

Biobot

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	May 3, 2024 7:56 PM	7406524e
public peers	general	May 3, 2024 7:56 PM	db7668c0
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 3, 2024 7:56 PM	21118630
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	589972fb
crunchbase profile	general
li profile	general	May 3, 2024 7:56 PM	8ea86d4e
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 3, 2024 7:56 PM	d6a60c41
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:BIOBOTSURGICAL

Biobot